Processa Pharmaceuticals, Inc. PCSA
NASDAQ · United States · Health Technology
$1.59-0.05 (-3.05%)
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise |
|---|---|---|---|---|
| Q4 2024 | 2025-03-20 | -18.50 | -23.00 | +19.6% |
| Q1 2024 | 2024-05-10 | -27.75 | -29.50 | +5.9% |
| Q4 2023 | 2024-03-29 | -203.50 | -40.00 | -408.8% |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.